Mukolitic phytotherapy in respiratory diseases: studies continue
https://doi.org/10.21518/2079-701X-2013-11-88-92
Abstract
About the Authors
N. A. ShostakRussian Federation
A. I. Kryukov
Russian Federation
N. L. Kunelskaya
Russian Federation
A. B. Turovskiy
Russian Federation
References
1. Gillissen A., Wittig Th., Ehmen M., Krezdorn H.G., de Mey C. A Multicentre, Randomised, Double-blind, Placebo-controlled Clinical Trial on the Efficacy and Tolerability of GeloMyrtol® forte in Acute Bronchitis // Drug. Research. 2013. Ausgabe eFirst.
2. Matthys H., de Mey C., Carls C., Rys A., Geib A., Wittig T. Efficacy and
3. Tolerability of Myrtol Standardized in Acute Bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol // Arzneimittel Forschung. 2000. №50. P. 700–711.
4. Behrbohm H., Kaschke O., Sydow K. Der EinfluB des pflanzlichen
5. Sekretolytikums Gelomyrtol® forte auf die mukoziliare Clearance der Kieferhohle // Laryngo-Rhino-Otol. 1995. №74. P. 733–737.
6. Kwok R.P. The effects of Gelomyrtol forte® on human ciliary beat frequency and intracellular cyclic adenosine monophosphate in vitro.
7. Dissertation for the degree of Master of Research in Medicine.
8. Division of Respiratory Medicine, Department of Medicine, Queen Mary Hospital, Hong Kong. 2007.
9. Крюков А.И., Туровский А.Б., Изотова Г.Н., Карюк Ю.А. Эффективность мукорегулирующей терапии при остром синусите // Медицинский совет. 2013. №3. С. 24–29.
Review
For citations:
Shostak NA, Kryukov AI, Kunelskaya NL, Turovskiy AB. Mukolitic phytotherapy in respiratory diseases: studies continue. Meditsinskiy sovet = Medical Council. 2013;(11):88-92. (In Russ.) https://doi.org/10.21518/2079-701X-2013-11-88-92